Extranodal Nk T-cell Lymphoma Nasal Type
📧 Sign up to get email alerts when something new happens for Extranodal Nk T-cell Lymphoma Nasal Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type [Phase 2]
Phase 2 clinical trial of IMC-001 in subjects with relapsed or refractory extranodal NK/T-cell lymphoma, nasal type; the study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma [NA]
A clinical trial update on a three-drug combination (Sintilimab, Chidamide, and Azacitidine) for untreated Stage I–II Extranodal NK/T-cell l…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas [Phase 1, Phase 2]
A study of DR-01 by Dren Bio is ongoing in Phase 1/Phase 2 to treat several T-cell and NK-cell lymphomas, with recruitment currently underwa…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating concurrent chemotherapy and radiation therapy for newly diagnosed nasal NK/T-cell lymphoma is currently …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma [Phase 1]
A Phase 1 trial evaluating vorinostat with azacitidine in adults with nasal-type extranodal NK/T-cell lymphoma or recurrent nasopharyngeal c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma [Phase 2]
Phase 2 screening study to evaluate combined sequential chemotherapy and radiation therapy for early-stage extranodal NK/T-cell lymphoma, na…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update of pembrolizumab with radiotherapy for extranodal NK/T-cell lymphoma; the study is currently active but not re…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL [Phase 2]
A Phase II trial is evaluating a three-drug combination (golidocitinib, pegaspargase, and a PD-1 antibody) as first-line therapy for advance…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma
Clinical trial update investigating the combination of tislelizumab with gemcitabine and pegaspargase for patients with primary stage I-II E…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type [Phase 2]
Phase 2 trial evaluating sintilimab with the P-GemOx regimen (gemcitabine + oxaliplatin) for newly diagnosed advanced extranodal NK/T-cell l…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma [Phase 3]
Phase 3 study evaluating Sugemalimab (or placebo) plus the PGemOx regimen in Extranodal NK/T-cell lymphoma; the trial status is NOT_YET_RECR…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma [Phase 1, Phase 2]
A Phase 1b/2 trial evaluating intravenous brincidofovir in relapsed or refractory lymphoma, including extranodal NK/T-cell lymphoma (ENKL), …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma [Phase 2]
A Phase 2 trial compares adding golidocitinib to a P-GemOx regimen plus a PD-1 inhibitor against P-GemOx plus a PD-1 inhibitor as first-line…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma [NA]
This clinical trial is evaluating a PET imaging approach and EBV DNA-directed therapy for localized nasal extranodal NK/T-cell lymphoma, and…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type [Phase 2]
Phase 2 study evaluating pembrolizumab in patients with early-stage extranodal NK/T-cell lymphoma, nasal type (nasal cavity or nasopharynx);…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma [Phase 2]
This entry describes a Phase II clinical trial evaluating dexamethasone, azacitidine, pegaspargase and tislelizumab with radiotherapy in pat…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL [Phase 1, Phase 2]
Phase Ib/II clinical study evaluating tislelizumab combined with golidocitinib and selinexor for relapsed/refractory natural killer/T-cell l…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Registry for People With T-cell Lymphoma
A registry study at Memorial Sloan Kettering Cancer Center to enroll people with various T-cell and NK-cell lymphomas; the trial is currentl…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
This clinical trial update describes a study evaluating PET imaging targeting Granzyme B as a biomarker to predict efficacy and prognosis in…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of Peg-asparaginase-based concurrent chemoradiotherapy in early-stage Extranodal…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma [Phase 3]
A Phase 3 trial comparing MESA versus ESA for early-stage Extranodal NK/T-cell Lymphoma, Nasal Type; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL [Phase 2]
Phase 2 clinical trial evaluating an anti-PD-1 antibody and pegaspargase with radiotherapy for early-stage Extranodal NK/T-cell Lymphoma, Na…
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for SHR-1210 in relapsed or refractory extranodal NK/T-cell lymphoma, nasal type.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: GPED Regimen for Relapsed/Refractory or Advanced ENKTCL [Phase 2]
Phase 2 trial update for GPED regimen in relapsed/refractory or advanced Extranodal NK/T-cell Lymphoma, Nasal Type.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating maintenance therapy with an anti-PD-1 antibody in extranodal NK/T-cell lymphoma, nasal type; status not specified.